Cargando…

Superselective embolization for high-flow priapism refractory to medical and surgical treatments

BACKGROUND: This study aimed to report long-term outcome of superselective embolization in patients with high-flow priapism refractory to medical and surgical treatments. METHODS: From August 2011 until July 2016, 14 patients with high-flow priapism refractory to local treatments were treated and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yonghua, Yi, Mengfei, Yu, Zepeng, Han, Xinwei, Ren, Jianzhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325169/
https://www.ncbi.nlm.nih.gov/pubmed/32605599
http://dx.doi.org/10.1186/s12894-020-00653-y
_version_ 1783552100857282560
author Bi, Yonghua
Yi, Mengfei
Yu, Zepeng
Han, Xinwei
Ren, Jianzhuang
author_facet Bi, Yonghua
Yi, Mengfei
Yu, Zepeng
Han, Xinwei
Ren, Jianzhuang
author_sort Bi, Yonghua
collection PubMed
description BACKGROUND: This study aimed to report long-term outcome of superselective embolization in patients with high-flow priapism refractory to medical and surgical treatments. METHODS: From August 2011 until July 2016, 14 patients with high-flow priapism refractory to local treatments were treated and their charts were retrospective reviewed. Clinical evaluation, color Doppler ultrasonography, arteriography and selective embolization were performed. Follow up was performed in all patients. Fourteen men (18–63 years old) were enrolled, with priapism duration of 14 h to 28 days. Internal pudendal arteries or glutaea inferior arteriae were successfully embolized with gelatin sponge particles, polyvinyl alcohol particles or microcoils. RESULTS: Pseudoaneurysm in right femoral artery was found in one case after intervention. The follow-up 1 week later showed that 13 patients were in good condition, the priapism diminished 1–7 days (mean 3.2 ± 0.5 days) after intervention, and 1 patient received second intervention. Mean follow-up was (range 10.8–69.6) months. One patient had recurrent priapism months after embolization and had his penis surgically removed for severe necrosis. CONCLUSIONS: Superselective embolization is safe and effective in high-flow priapism refractory local treatments, with a good long-term prognosis.
format Online
Article
Text
id pubmed-7325169
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73251692020-06-30 Superselective embolization for high-flow priapism refractory to medical and surgical treatments Bi, Yonghua Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang BMC Urol Research Article BACKGROUND: This study aimed to report long-term outcome of superselective embolization in patients with high-flow priapism refractory to medical and surgical treatments. METHODS: From August 2011 until July 2016, 14 patients with high-flow priapism refractory to local treatments were treated and their charts were retrospective reviewed. Clinical evaluation, color Doppler ultrasonography, arteriography and selective embolization were performed. Follow up was performed in all patients. Fourteen men (18–63 years old) were enrolled, with priapism duration of 14 h to 28 days. Internal pudendal arteries or glutaea inferior arteriae were successfully embolized with gelatin sponge particles, polyvinyl alcohol particles or microcoils. RESULTS: Pseudoaneurysm in right femoral artery was found in one case after intervention. The follow-up 1 week later showed that 13 patients were in good condition, the priapism diminished 1–7 days (mean 3.2 ± 0.5 days) after intervention, and 1 patient received second intervention. Mean follow-up was (range 10.8–69.6) months. One patient had recurrent priapism months after embolization and had his penis surgically removed for severe necrosis. CONCLUSIONS: Superselective embolization is safe and effective in high-flow priapism refractory local treatments, with a good long-term prognosis. BioMed Central 2020-06-30 /pmc/articles/PMC7325169/ /pubmed/32605599 http://dx.doi.org/10.1186/s12894-020-00653-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Bi, Yonghua
Yi, Mengfei
Yu, Zepeng
Han, Xinwei
Ren, Jianzhuang
Superselective embolization for high-flow priapism refractory to medical and surgical treatments
title Superselective embolization for high-flow priapism refractory to medical and surgical treatments
title_full Superselective embolization for high-flow priapism refractory to medical and surgical treatments
title_fullStr Superselective embolization for high-flow priapism refractory to medical and surgical treatments
title_full_unstemmed Superselective embolization for high-flow priapism refractory to medical and surgical treatments
title_short Superselective embolization for high-flow priapism refractory to medical and surgical treatments
title_sort superselective embolization for high-flow priapism refractory to medical and surgical treatments
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325169/
https://www.ncbi.nlm.nih.gov/pubmed/32605599
http://dx.doi.org/10.1186/s12894-020-00653-y
work_keys_str_mv AT biyonghua superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments
AT yimengfei superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments
AT yuzepeng superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments
AT hanxinwei superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments
AT renjianzhuang superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments